MDLN on Nasdaq
Medline Inc.
American surgical and medical instruments and apparatus company.
$35.92 down 0.65 (1.78%)Price as of Oct 16, 2026 at 19:58 UTC
Last updated Oct 18, 2026.
Overview
Compare with Stryker Corporation, 3M or Becton Dickinson, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue74¢$20.9B
- Research and development0¢$80.0M
- Selling, general and admin16¢$4.5B
- Other costs6¢$1.7B
- Income tax0¢$91.0M
- Profit4¢$1.2B
Out of $28.4B in revenue.3
Where each dollar of operating cash went, fiscal 2025
- Capital spending26¢$447.0M
- Share buybacks2¢$33.0M
- Kept or used elsewhere72¢$1.3B
Out of $1.7B of cash from operations.3
Financial statements
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $23.2B3 | $25.5B3 | $28.4B3 | |
| Cost of revenue | $17.3B3 | $18.5B3 | $20.9B3 | |
| Gross profit | $5.9B3 | $7.0B3 | $7.5B3 | |
| Research and development | $60.0M3 | $67.0M3 | $80.0M3 | |
| Selling, general and admin | $3.9B3 | $4.1B3 | $4.5B3 | |
| Operating income | $1.2B3 | $2.1B3 | $2.2B3 | |
| Income tax | $30.0M3 | $46.0M3 | $91.0M3 | |
| Net income | $234.0M3 | $1.2B3 | $1.2B3 | |
| Earnings per share | -$0.013 | |||
| Earnings per share (diluted) | -$0.013 |
Leadership
Who has led Medline Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerJames M. Boyle Dec 17, 2025 to now7
- PresidentJames M. Pigott Dec 17, 2025 to now8
- Chief financial officerMichael B. Drazin Dec 17, 2025 to now9
Board members and other officers (16)
- Principal Accounting OfficerJessi L. Corcoran Mar 6, 2026 to now10
- Chief Product OfficerAmanda H. Laabs Dec 17, 2025 to now11
- Chief Human Resources OfficerChristopher P. Shryock Dec 17, 2025 to now12
- Chief Commercial OfficerDouglas P. Golwas Dec 17, 2025 to now13
- OfficerWilliam J. Abrams Dec 17, 2025 to now14
- Board memberRobert R. Schmidt Jan 8, 2026 to now15
- Board memberStephen H. Wise Jan 8, 2026 to now16
- Board memberAnushka M. Sunder Dec 17, 2025 to now17
- Board memberJacob Best Dec 17, 2025 to now18
- Board memberJames M. Boyle Dec 17, 2025 to now7
- Board memberJoseph Baratta Dec 17, 2025 to now19
- Board memberPatrick J. Healy Dec 17, 2025 to now20
- Board memberRichard Galanti Dec 17, 2025 to now21
- Board memberThomas W. Sweet Dec 17, 2025 to now22
- Board memberTodd M. Bluedorn Dec 17, 2025 to now23
- General counselAlexander M. Liberman Dec 17, 2025 to now24
Timeline
Filings
152 filings to the SEC since October 2021: 1 annual reports, 2 quarterly reports, 8 major events, 98 insider forms, 11 large holders, 32 other. The latest 20:
- Oct 15, 20268-K EDGAR
- Oct 13, 20264 EDGAR
- Oct 6, 20264 EDGAR
- Aug 21, 20264 EDGAR
- Aug 21, 20264 EDGAR
- Aug 17, 20264 EDGAR
- Aug 11, 2026SCHEDULE 13G/A EDGAR
- Aug 11, 20264 EDGAR
- Aug 7, 2026SCHEDULE 13G/A EDGAR
- Aug 7, 20264 EDGAR
- Aug 7, 20264 OWNERSHIP DOCUMENT EDGAR
- Aug 6, 2026SCHEDULE 13G EDGAR
- Aug 5, 202610-Q EDGAR
- Aug 5, 20268-K EDGAR
- Jul 9, 20268-K EDGAR
- Jun 17, 20264 EDGAR
- Jun 17, 20264 EDGAR
- Jun 17, 20264 EDGAR
- Jun 17, 20264 EDGAR
- Jun 17, 20264 EDGAR
The 152 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 11 such filings since October 2021, the latest 10:
- Aug 11, 2026SCHEDULE 13G/A
- Aug 7, 2026SCHEDULE 13G/A
- Aug 6, 2026SCHEDULE 13G
- May 7, 2026SCHEDULE 13G/A
- May 6, 2026SCHEDULE 13G/A
- May 1, 2026SCHEDULE 13G/A
- Feb 13, 2026SCHEDULE 13G
- Feb 13, 2026SCHEDULE 13G
- Feb 13, 2026SCHEDULE 13G
- Feb 11, 2026SCHEDULE 13G
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Carlyle Group Inc. | 187,083,713 | $7.4B | 73.8% | No change |
| H&F Corporate Investors X, Ltd. | 70,874,326 | $2.8B | 100.0% | −15,599,171 |
| Fmr LLC | 46,963,203 | $1.9B | 0.1% | +10,407,002 |
| Capital Research Global Investors | 39,963,790 | $1.6B | 0.2% | +16,802,120 |
| Invesco Ltd. | 38,346,937 | $1.5B | 0.1% | +17,383,322 |
| BlackRock, Inc. | 26,393,587 | $1.0B | 0.0% | +9,469,927 |
| Morgan Stanley | 21,605,662 | $852.1M | 0.0% | +5,902,759 |
| Lone Pine Capital LLC | 20,968,367 | $827.0M | 5.1% | +9,179,211 |
| Massachusetts Financial Services Co /ma/ | 19,888,806 | $787.1M | 0.3% | +8,319,490 |
| Vanguard Capital Management LLC | 17,816,057 | $702.7M | 0.0% | +3,086,376 |
| Vanguard Portfolio Management LLC | 16,781,031 | $661.8M | 0.0% | +2,630,279 |
| Egerton Capital (UK) LLP | 16,470,884 | $649.6M | 6.3% | +12,105,082 |
| Jupiter Topco LLC | 15,858,400 | $625.4M | 0.3% | New |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 11,956,905 | $471.6M | 0.4% | +7,572,176 |
| Baillie Gifford & Co | 11,343,036 | $447.4M | 0.4% | +1,367,261 |
| Norges Bank | 8,475,413 | $334.3M | 0.0% | New |
| State Street Corp | 8,447,035 | $333.2M | 0.0% | +3,624,652 |
| Geode Capital Management, LLC | 7,948,506 | $312.7M | 0.0% | +1,690,234 |
| SurgoCap Partners LP | 7,487,507 | $295.3M | 9.5% | +1,412,342 |
| Wcm Investment Management, LLC | 7,397,650 | $293.0M | 0.5% | +178,919 |
| Healthcare Of Ontario Pension Plan Trust Fund | 7,355,574 | $290.1M | 0.4% | +2,355,574 |
| Banque Pictet & Cie Sa | 7,312,150 | $288.4M | 3.0% | +5,891,183 |
| Alyeska Investment Group, L.P. | 6,809,122 | $268.6M | 0.7% | +3,871,733 |
| UBS Group AG | 6,431,013 | $253.6M | 0.0% | +3,239,352 |
| Viking Global Investors LP | 4,841,080 | $190.9M | 0.5% | −6,592,912 |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARMedline Inc. filings on SEC EDGAR
- 2Yahoo FinanceMDLN quote
- 3SEC EDGARMedline Inc. 10-K for fiscal 2025
- 4SEC EDGARMedline Inc. filings on SEC EDGAR
- 5SEC EDGARMedline Inc. 10-Q for fiscal 2025
- 6SEC EDGARMedline Inc. 10-Q for fiscal 2025
- 7
- 8SEC EDGARJames M. Pigott, President
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARWilliam J. Abrams, Officer
- 15SEC EDGARRobert R. Schmidt, Board member
- 16SEC EDGARStephen H. Wise, Board member
- 17SEC EDGARAnushka M. Sunder, Board member
- 18SEC EDGARJacob Best, Board member
- 19SEC EDGARJoseph Baratta, Board member
- 20SEC EDGARPatrick J. Healy, Board member
- 21SEC EDGARRichard Galanti, Board member
- 22SEC EDGARThomas W. Sweet, Board member
- 23SEC EDGARTodd M. Bluedorn, Board member
- 24
- 25